Portfolio comparison
Immatics Biotechnologies vs Constantin Fahlberg
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Immatics Biotechnologies
Patents indexed
3
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapygene_editingoncology
Top Patents3 enriched
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
US 12168044· 2024
Treating Liver Cancer with Specially Trained Immune Cells
US 11542303· 2023
How a Specific Peptide Boosts the Immune System Against Cancer
Activity by Decade
2010s1
2020s2
Company B
Constantin Fahlberg
Patents indexed
1
Year range
1885
Most recent
1885
biotechchemical_manufacturing
Top Patents1 enriched
US 319082· 1885
How Constantin Fahlberg Discovered Saccharin
Activity by Decade
1880s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.